Average Co-Inventor Count = 5.50
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceuticals, Inc. (20 from 159 patents)
2. Katholieke Universiteit Leuven (19 from 346 patents)
3. Tibotec Pharmaceuticals Ltd. (7 from 67 patents)
4. Janssen Sciences Ireland Uc (4 from 111 patents)
5. Janssen Sciences Ireland Unlimited Company (2 from 61 patents)
6. Janssen Vaccines & Prevention B.v. (1 from 115 patents)
7. Janssen R&d Ireland (1 from 45 patents)
8. Tibotec Bvba (1 from 13 patents)
9. Kathalieke Universiteif Leuven (1 from 1 patent)
10. Medivir Ab (120 patents)
36 patents:
1. 12172959 - Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
2. 11827602 - Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
3. 11795149 - Substituted indoline derivatives as dengue viral replication inhibitors
4. 11702387 - Substituted indoline derivatives as dengue viral replication inhibitors
5. 11491148 - Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
6. 11407715 - Substituted indoline derivatives as dengue viral replication inhibitors
7. 11179368 - Substituted indoline derivatives as dengue viral replication inhibitors
8. 11180450 - Substituted indoline derivatives as dengue viral replication inhibitors
9. 11096931 - Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
10. 11083707 - Substituted indoline derivatives as dengue viral replication inhibitors
11. 11053196 - Substituted indoline derivatives as dengue viral replication inhibitors
12. 10919854 - Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
13. 10913716 - Substituted indoline derivatives as dengue viral replication inhibitors
14. 10786484 - Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
15. 10765662 - Mono- or di-substituted indole derivatives as dengue viral replication inhibitors